Section 232 Steel Tariffs: Announcement of Major Legal Challenge
American Institute for International Steel Initiative is First of its Kind
American Institute for International Steel:
|
WHAT |
Steel Tariff Legal Challenge: Major Announcement Pending from AIIS |
|
|
WHEN |
Wednesday, June 27, 2018, 10:00 – 11:00 AM (Media Registration: 9:45 AM) |
|
|
WHERE |
National Press Club, 529 14th Street NW, 13th Floor, Washington, D.C. 20045 |
|
|
Edward R. Murrow Room |
||
|
WHO |
Richard Chriss, President, American Institute for International Steel |
|
|
AIIS Legal Team |
||
|
WHY |
President Trump’s Section 232 tariffs on imported steel and aluminum have already created significant collateral damage for U.S. industries. American ports and steel importing companies are seeing throughput decline sharply. Meanwhile, U.S. steel-using manufacturers are encountering product price increases of 50% or more and are experiencing difficulty in obtaining the steel they need, regardless of whether they buy domestic-sourced or imported steel. |
|
| This briefing will announce the launch of a legal challenge that seeks to remedy a situation that is bad for the American economy and American workers alike. The legal action will commence Wednesday morning, with attorneys available at the press conference to describe and discuss this critically important, first-of-its-kind initiative. | ||
|
About AIIS |
The American Institute for International Steel, representing 120 member companies, is America’s leading voice for the steel supply chain, and the only voice in Washington, D.C. for free and responsible trade in steel. | |
|
Contact: |
Amelia Berger, [email protected], 202-828-1727 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20180626006175/en/
for American Institute for International Steel (AIIS)
Amelia
Berger, 202-828-1727
[email protected]
Source: American Institute for International Steel (AIIS)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incannex doses first patient in IHL-42X sleep apnea study
- EDX Markets adds Figure's YLDS as collateral and treasury asset
- Polaryx targets Q4 2026 launch of SOTERIA Phase 2 trial
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Raising PricesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share